Carson W. King , Puppala Sathish , Danielle N. Turner , Arben Zejnelovski , Vincent T. Do , Robert Rubiano , David Schilter , Todd W. Hudnall , Snezna Rogelj , Alexander Kornienko
{"title":"Synthesis and antibacterial activity of 3-(arylazo)indoles and related azoheterocycles","authors":"Carson W. King , Puppala Sathish , Danielle N. Turner , Arben Zejnelovski , Vincent T. Do , Robert Rubiano , David Schilter , Todd W. Hudnall , Snezna Rogelj , Alexander Kornienko","doi":"10.1016/j.bmcl.2025.130256","DOIUrl":null,"url":null,"abstract":"<div><div>Methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) is a major cause of hospitalizations and mortality from bacterial infections and is considered a national priority for disease control. In this work we synthesized and evaluated twenty novel C-3 arylazo-coupled indoles and one 4-arylazo-benzo[<em>d</em>]imidazole. The substituents on the C3-aromatic moiety included alkyl, halogen, amino, alkoxy, alkylsulfonyl at positions <em>ortho</em>, <em>meta</em> and <em>para</em>. The indoles utilized were 4-bromo, 5,6-methylenedioxy, 7-aza. In this effort, several azo-indoles showed promising anti-MRSA activities with MIC values as low as 3 μM. Another important finding of this work that sets that stage for a further larger investigation is that 4-arylazo-benzo[<em>d</em>]imidazole is a previously unexplored scaffold with potent anti-MRSA activity.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"124 ","pages":"Article 130256"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960894X25001659","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospitalizations and mortality from bacterial infections and is considered a national priority for disease control. In this work we synthesized and evaluated twenty novel C-3 arylazo-coupled indoles and one 4-arylazo-benzo[d]imidazole. The substituents on the C3-aromatic moiety included alkyl, halogen, amino, alkoxy, alkylsulfonyl at positions ortho, meta and para. The indoles utilized were 4-bromo, 5,6-methylenedioxy, 7-aza. In this effort, several azo-indoles showed promising anti-MRSA activities with MIC values as low as 3 μM. Another important finding of this work that sets that stage for a further larger investigation is that 4-arylazo-benzo[d]imidazole is a previously unexplored scaffold with potent anti-MRSA activity.
期刊介绍:
Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.